Geratherm Medical AG (GME.DE)
EUR 3.09
(-1.9%)
EUR 3.09
(-1.9%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 11.67 Million EUR | -20.21% |
| 2022 | 14.63 Million EUR | -8.11% |
| 2021 | 15.92 Million EUR | -0.85% |
| 2020 | 16.06 Million EUR | 14.07% |
| 2019 | 14.08 Million EUR | 52.21% |
| 2018 | 9.25 Million EUR | 24.2% |
| 2017 | 7.44 Million EUR | -5.05% |
| 2016 | 7.84 Million EUR | -5.57% |
| 2015 | 8.3 Million EUR | 1.99% |
| 2014 | 8.14 Million EUR | -5.46% |
| 2013 | 8.61 Million EUR | -1.67% |
| 2012 | 8.76 Million EUR | 48.08% |
| 2011 | 5.91 Million EUR | -37.34% |
| 2010 | 9.44 Million EUR | 89.59% |
| 2009 | 4.98 Million EUR | 106.42% |
| 2008 | 2.41 Million EUR | 26.2% |
| 2007 | 1.91 Million EUR | 21.66% |
| 2006 | 1.57 Million EUR | 9.82% |
| 2005 | 1.43 Million EUR | -31.89% |
| 2004 | 2.1 Million EUR | -21.24% |
| 2003 | 2.66 Million EUR | -16.92% |
| 2002 | 3.21 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | 13.1 Million EUR | -12.44% |
| 2023 Q2 | 14.96 Million EUR | 0.0% |
| 2023 Q1 | 14.96 Million EUR | -7.32% |
| 2023 Q4 | 13.1 Million EUR | 0.0% |
| 2023 FY | 11.67 Million EUR | -20.21% |
| 2022 Q2 | 17.59 Million EUR | 4.37% |
| 2022 FY | 14.63 Million EUR | -8.11% |
| 2022 Q3 | 18.48 Million EUR | 5.04% |
| 2022 Q4 | 16.15 Million EUR | -12.6% |
| 2022 Q1 | 16.85 Million EUR | 5.83% |
| 2021 Q1 | 16.02 Million EUR | -0.24% |
| 2021 Q3 | 15.5 Million EUR | -2.61% |
| 2021 FY | 15.92 Million EUR | -0.85% |
| 2021 Q2 | 15.91 Million EUR | -0.67% |
| 2021 Q4 | 15.92 Million EUR | 2.75% |
| 2020 Q2 | 16.08 Million EUR | 7.57% |
| 2020 FY | 16.06 Million EUR | 14.07% |
| 2020 Q3 | 16.25 Million EUR | 1.05% |
| 2020 Q4 | 16.06 Million EUR | -1.15% |
| 2020 Q1 | 14.95 Million EUR | 6.15% |
| 2019 Q4 | 14.08 Million EUR | 2.19% |
| 2019 FY | 14.08 Million EUR | 52.21% |
| 2019 Q2 | 11.12 Million EUR | 7.92% |
| 2019 Q3 | 13.78 Million EUR | 23.89% |
| 2019 Q1 | 10.3 Million EUR | 11.41% |
| 2018 Q3 | 8.57 Million EUR | 4.94% |
| 2018 Q1 | 7.34 Million EUR | -1.41% |
| 2018 FY | 9.25 Million EUR | 24.2% |
| 2018 Q4 | 9.25 Million EUR | 7.95% |
| 2018 Q2 | 8.16 Million EUR | 11.21% |
| 2017 Q3 | 7.7 Million EUR | 21.81% |
| 2017 Q2 | 6.32 Million EUR | -10.2% |
| 2017 Q1 | 7.04 Million EUR | -10.17% |
| 2017 FY | 7.44 Million EUR | -5.05% |
| 2017 Q4 | 7.44 Million EUR | -3.37% |
| 2016 Q3 | 7.1 Million EUR | -2.87% |
| 2016 FY | 7.84 Million EUR | -5.57% |
| 2016 Q2 | 7.31 Million EUR | -6.11% |
| 2016 Q1 | 7.79 Million EUR | -6.19% |
| 2016 Q4 | 7.84 Million EUR | 10.38% |
| 2015 Q3 | 7.18 Million EUR | -11.75% |
| 2015 FY | 8.3 Million EUR | 1.99% |
| 2015 Q4 | 8.3 Million EUR | 15.63% |
| 2015 Q1 | 8.29 Million EUR | 1.87% |
| 2015 Q2 | 8.14 Million EUR | -1.89% |
| 2014 Q2 | 8.48 Million EUR | -0.66% |
| 2014 Q1 | 8.53 Million EUR | -0.91% |
| 2014 FY | 8.14 Million EUR | -5.46% |
| 2014 Q4 | 8.14 Million EUR | -6.79% |
| 2014 Q3 | 8.73 Million EUR | 3.04% |
| 2013 Q1 | 8.55 Million EUR | -2.35% |
| 2013 FY | 8.61 Million EUR | -1.67% |
| 2013 Q4 | 8.61 Million EUR | -0.31% |
| 2013 Q3 | 8.64 Million EUR | 1.04% |
| 2013 Q2 | 8.55 Million EUR | -0.03% |
| 2012 Q1 | 5.77 Million EUR | -2.36% |
| 2012 FY | 8.76 Million EUR | 48.08% |
| 2012 Q2 | 5.84 Million EUR | 1.08% |
| 2012 Q3 | 5.48 Million EUR | -6.15% |
| 2012 Q4 | 8.76 Million EUR | 59.87% |
| 2011 Q1 | 5.69 Million EUR | -39.66% |
| 2011 Q2 | 5.8 Million EUR | 1.86% |
| 2011 Q3 | 6.33 Million EUR | 9.22% |
| 2011 Q4 | 5.91 Million EUR | -6.65% |
| 2011 FY | 5.91 Million EUR | -37.34% |
| 2010 Q4 | 9.44 Million EUR | 68.95% |
| 2010 FY | 9.44 Million EUR | 89.59% |
| 2010 Q1 | 5.52 Million EUR | 10.91% |
| 2010 Q2 | 5.47 Million EUR | -0.97% |
| 2010 Q3 | 5.59 Million EUR | 2.17% |
| 2009 FY | 4.98 Million EUR | 106.42% |
| 2009 Q2 | 2.76 Million EUR | 0.0% |
| 2009 Q4 | 4.98 Million EUR | 0.0% |
| 2008 FY | 2.41 Million EUR | 26.2% |
| 2007 FY | 1.91 Million EUR | 21.66% |
| 2006 FY | 1.57 Million EUR | 9.82% |
| 2005 FY | 1.43 Million EUR | -31.89% |
| 2004 FY | 2.1 Million EUR | -21.24% |
| 2003 FY | 2.66 Million EUR | -16.92% |
| 2002 FY | 3.21 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| aap Implantate AG | 8.62 Million EUR | -35.413% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 99.368% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 99.368% |
| elexxion AG | 4567.05 EUR | -255631.008% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 215.27 Million EUR | 94.575% |
| Koninklijke Philips N.V. | 17.34 Billion EUR | 99.933% |
| Stratec SE | 246.2 Million EUR | 95.256% |
| Siemens Healthineers AG | 28.55 Billion EUR | 99.959% |